Please use this identifier to cite or link to this item:
https://www.arca.fiocruz.br/handle/icict/29135
Type
ArticleCopyright
Open access
Embargo date
2019-09-18
Collections
- INI - Artigos de Periódicos [3381]
- IOC - Artigos de Periódicos [12482]
Metadata
Show full item record
HUMAN IMMUNODEFICIENCY VIRUS ANTIRETROVIRAL RESISTANCE AND TRANSMISSION IN MOTHER-INFANT PAIRS ENROLLED IN A LARGE PERINATAL STUDY
Author
Affilliation
Department of Pediatrics, David Geffen School of Medicine, University of California, Los Angeles.
Department of Pediatrics, David Geffen School of Medicine, University of California, Los Angeles.
Department of Pediatrics, David Geffen School of Medicine, University of California, Los Angeles.
Office of the Global AIDS Coordinator and Health Diplomacy, US Department of State, Washington D.C.,USA.
Westat. Rockville, Maryl, USA.
Hospital Federal dos Servidores do Estado. Rio de Janeiro, RJ, Brasil.
Hospital Geral de Nova Iguaçu, Rio de Janeiro, RJ, Brasil / Fundação Oswaldo Cruz. Instituto Oswaldo Cruz. Laboratório de AIDS e Imunologia Molecular. Rio de Janeiro, RJ, Brasil.
Fundação Oswaldo Cruz. Instituto Nacional de Infectologia Evandro Chagas. Laboratório de Pesquisa Clínica em DST/AIDS. Rio de Janeiro, RJ, Brasil.
Department of Pediatrics. David Geffen School of Medicine. University of California. Los Angeles, USA.
Chris Hani Baragwanath Hospital. University of the Witwatersrand. Johannesburg.
Department of Obstetrics and Gynecology. Stellenbosch University. Cape Town, South Africa.
Department of Pediatrics. David Geffen School of Medicine. University of California. Los Angeles, USA.
Fundação Oswaldo Cruz. Instituto Oswaldo Cruz. Rio de Janeiro, RJ, Brasil.
Hospital Conceicao, Porto Alegre, RS, Brasil.
Hospital Femina, Porto Alegre, RS, Brasil.
Elizabeth Glaser Pediatric AIDS Foundation. Washington D.C, USA.
Department of Pediatrics, David Geffen School of Medicine, University of California, Los Angeles, USA.
Department of Pediatrics, David Geffen School of Medicine, University of California, Los Angeles.
Department of Pediatrics, David Geffen School of Medicine, University of California, Los Angeles.
Office of the Global AIDS Coordinator and Health Diplomacy, US Department of State, Washington D.C.,USA.
Westat. Rockville, Maryl, USA.
Hospital Federal dos Servidores do Estado. Rio de Janeiro, RJ, Brasil.
Hospital Geral de Nova Iguaçu, Rio de Janeiro, RJ, Brasil / Fundação Oswaldo Cruz. Instituto Oswaldo Cruz. Laboratório de AIDS e Imunologia Molecular. Rio de Janeiro, RJ, Brasil.
Fundação Oswaldo Cruz. Instituto Nacional de Infectologia Evandro Chagas. Laboratório de Pesquisa Clínica em DST/AIDS. Rio de Janeiro, RJ, Brasil.
Department of Pediatrics. David Geffen School of Medicine. University of California. Los Angeles, USA.
Chris Hani Baragwanath Hospital. University of the Witwatersrand. Johannesburg.
Department of Obstetrics and Gynecology. Stellenbosch University. Cape Town, South Africa.
Department of Pediatrics. David Geffen School of Medicine. University of California. Los Angeles, USA.
Fundação Oswaldo Cruz. Instituto Oswaldo Cruz. Rio de Janeiro, RJ, Brasil.
Hospital Conceicao, Porto Alegre, RS, Brasil.
Hospital Femina, Porto Alegre, RS, Brasil.
Elizabeth Glaser Pediatric AIDS Foundation. Washington D.C, USA.
Department of Pediatrics, David Geffen School of Medicine, University of California, Los Angeles, USA.
Abstract
The presence of antiretroviral drug-associated resistance mutations (DRMs) may be particularly problematic in human immunodeficiency virus (HIV)-infected pregnant women as it can lead to mother-to-child transmission (MTCT) of resistant HIV strains. This study evaluated the prevalence and the effect of antiretroviral DRMs in previously untreated mother-infant pairs.
Share